We are pleased to share with you the latest podcast from HypoPara Unscripted, which is produced by the Hypoparathyroidism Association.
In this episode of HypoPara Unscripted, Patty sits down for a gripping conversation with industry veteran Stewart Hallett to speak about the difference between biotech and big pharma. Thanks to his notable experience, Stewart reveals the complex journey of drug development, how clinical trials work, as well as the billions in cost and just how long it takes to successfully bring a drug to market. Stewart and Patty also uncover the undisputed importance of the patient voice as an integral part of the process. This leads Stewart to share a powerful, personal story one which shaped his career and his belief that it must always be “about the patient”. Join Patty for this enlightening episode and find out what it all means for the HypoPara community.
